GoodRx CFO Huguet Secures New Employment Agreement
Ticker: GDRX · Form: 8-K · Filed: Mar 7, 2024 · CIK: 1809519
| Field | Detail |
|---|---|
| Company | Goodrx Holdings, Inc. (GDRX) |
| Form Type | 8-K |
| Filed Date | Mar 7, 2024 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.0001, $450,000, $2,500,000, $2,500,000 b, $162,792 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, employment-agreement, cfo
Related Tickers: GDRX
TL;DR
GoodRx CFO Jerome Huguet signed a new employment deal, locking him in.
AI Summary
GoodRx Holdings, Inc. announced on March 4, 2024, that its Chief Financial Officer, Jerome Huguet, has entered into a new employment agreement. The agreement outlines his compensation and terms of employment with the company.
Why It Matters
This filing confirms the continued employment and compensation structure for GoodRx's CFO, providing clarity for investors regarding key executive leadership.
Risk Assessment
Risk Level: low — The filing pertains to a standard executive employment agreement, not a significant event like a merger or major financial distress.
Key Players & Entities
- GoodRx Holdings, Inc. (company) — The company filing the report.
- Jerome Huguet (person) — Chief Financial Officer of GoodRx Holdings, Inc.
- March 4, 2024 (date) — The date of the earliest event reported.
FAQ
What is the effective date of Jerome Huguet's new employment agreement?
The earliest event reported is dated March 4, 2024, indicating the agreement is effective around this time.
What is Jerome Huguet's role at GoodRx Holdings, Inc.?
Jerome Huguet is the Chief Financial Officer (CFO) of GoodRx Holdings, Inc.
What type of SEC filing is this?
This is a Form 8-K, a current report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Where is GoodRx Holdings, Inc. headquartered?
GoodRx Holdings, Inc. is located at 2701 Olympic Boulevard, Santa Monica, California 90404.
What is the primary purpose of this 8-K filing?
The filing reports on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, specifically detailing the CFO's employment agreement.
Filing Stats: 1,414 words · 6 min read · ~5 pages · Grade level 13.7 · Accepted 2024-03-07 17:20:57
Key Financial Figures
- $0.0001 — hich registered Class A Common Stock, $0.0001 par value per share GDRX The Nasdaq Sto
- $450,000 — to (i) receive an annual base salary of $450,000, which may be adjusted by the Board of
- $2,500,000 — Equity Awards"), each having a value of $2,500,000, under the Company's 2020 Incentive Awa
- $2,500,000 b — ty Award will be determined by dividing $2,500,000 by (i) in the case of the Option Award, t
- $162,792 — me discretionary bonus in the amount of $162,792 (the "Special Bonus") to Mr. Voermann i
Filing Documents
- gdrx-8xkxitem502cfoagreeme.htm (8-K) — 30KB
- goodrx-employmentagreement.htm (EX-10.1) — 129KB
- 0001809519-24-000041.txt ( ) — 161KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits . The following exhibits are included with this Current Report on Form 8-K 10.1 Employment Agreement, by and between GoodRx, Inc. and Karsten Voermann, dated March 4, 2024 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GOODRX HOLDINGS, INC. Date March 7, 2024 By s Scott Wagner Name Scott Wagner Title Interim Chief Executive Officer